Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. [electronic resource]
Producer: 19960111Description: 1-6 p. digitalISSN:- 0028-4793
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Neutropenia -- chemically induced
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Prospective Studies
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.